Use of telemedicine to assist in the diagnosis of multiple sclerosis from a clinically isolated syndrome

Multiple sclerosis (MS) is a neurological autoimmune disease that affects nearly 100,000 Canadians between the ages of 20 and 49 [1]. The damages myelin, protective layer surrounding nerves, which causes irreversible damage to central nervous system (CNS) Common symptoms for patients with MS include vision impairment, loss coordination, cognitive impairment. As 2015, life expectancy approximately 7 years shorter than general population, cause death due itself or related conditions such as infections [1, 2]. Despite significant global prevalence its severity, no cure has been discovered, instead all approved treatments merely aim slow down progression such, timely diagnosis critical minimize more severe early in [3].